Saudi Arabia Succeeds In Utilizing Casgevy To Treat Inherited Blood Disorder
Date
8/29/2024 7:17:15 PM
(MENAFN- Kuwait News Agency (KUNA))
RIYADH, Aug 29 (KUNA) -- The Kingdom of Saudi Arabia has made a medical breakthrough, with King Abdulaziz Medical City in Riyadh (KAMC-RD) of the Ministry of National Guard - health Affairs (MNGHA) successfully utilizing Casgevy gene therapy through CRISPR gene editing technology to treat a 13-year-old patient with thalassemia major.
The achievement is the first of its kind outside clinical trials and research, the Saudi Press Agency reported on Thursday.
The patient, who had been reliant on blood transfusions every three weeks since birth, left the medical city after the successful transplantation of gene cells, making a complete recovery, according to the SPA report.
The Kingdom is preparing to soon implement more of these advanced gene therapies for several patients with sickle cell anemia and thalassemia, further solidifying its position in the field of gene therapy on a global scale. (end)
hss
MENAFN29082024000071011013ID1108617570
.jpg)
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.